Inventor · disambiguated record
Phong X. Nguyen
Also filed as: NGUYEN PHONG · NGUYEN PHONG X
50 granted patents·21 pending applications·661 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
71 records- 0197US7091232B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2003·Granted Aug 15, 2006·112 cites·3 claims
- 0296US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0396US6737418B2Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereofEURO CELTIQUE SA·Filed 2002·Granted May 18, 2004·104 cites·39 claims
- 0496US6414011B1Aryl substituted pyrazoles, and pyrroles, and the use thereofEURO CELTIQUE SA·Filed 2000·Granted Jul 2, 2002·135 cites·47 claims
- 0593US6867210B2Aryl substituted pyrimidinesEURO CELTIQUE SA·Filed 2001·Granted Mar 15, 2005·49 cites·57 claims
- 0692US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0792US7323477B27-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinolineALLERGAN INC·Filed 2006·Granted Jan 29, 2008·22 cites·11 claims
- 0892US7276522B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2004·Granted Oct 2, 2007·44 cites·3 claims
- 0990US7943641B27-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinolineALLERGAN INC·Filed 2008·Granted May 17, 2011·7 cites·2 claims
- 1090US7345077B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2005·Granted Mar 18, 2008·12 cites·20 claims
- 1190US7078426B2Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereofEURO CELTIQUE SA·Filed 2001·Granted Jul 18, 2006·46 cites·21 claims
- 1290US6919363B2Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereofEURO CELTIQUE SA·Filed 2003·Granted Jul 19, 2005·45 cites·20 claims
- 1389US7399868B24-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 15, 2008·11 cites·7 claims
- 1488US7419994B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compoundsALLERGAN INC·Filed 2006·Granted Sep 2, 2008·8 cites·16 claims
- 1587US8063231B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Nov 22, 2011·4 cites·1 claims
- 1684US8329918B2Selective alpha 2B/2C agonistsNGUYEN PHONG X·Filed 2010·Granted Dec 11, 2012·7 cites·2 claims
- 1783US7396849B24-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 1882US8071636B2Methods of treating alpha adrenergic mediated conditionsFANG WENKUI K·Filed 2009·Granted Dec 6, 2011·4 cites·17 claims
- 1982US8063087B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compoundsCHOW KEN·Filed 2008·Granted Nov 22, 2011·4 cites·9 claims
- 2082US7683089B14-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Mar 23, 2010·4 cites·2 claims
- 2181US7569584B24-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the sameALLERGAN INC·Filed 2007·Granted Aug 4, 2009·4 cites·11 claims
- 2280US2023062049A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2021·Application pending·0 cites
- 2379US9849113B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2017·Granted Dec 26, 2017·1 cites·5 claims
- 2477US9572792B2Coumarin compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2015·Granted Feb 21, 2017·2 cites·5 claims
- 2577US8653270B2Compounds as receptor modulators with therapeutic utilityHEIDELBAUGH TODD M·Filed 2011·Granted Feb 18, 2014·3 cites·17 claims
- 2677US8013169B2Naphthylmethylimidizoles as therapeutic agentsALLERGAN INC·Filed 2008·Granted Sep 6, 2011·2 cites·13 claims
- 2777US7868020B2Quinolynylmethylimidizoles as therapeutic agentsALLERGAN INC·Filed 2008·Granted Jan 11, 2011·2 cites·15 claims
- 2877US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2975US9623006B2Methods of treating α adrenergic mediated conditionsALLERGAN INC·Filed 2015·Granted Apr 18, 2017·1 cites·5 claims
- 3073US9034910B2Methods of treating alpha adrenergic mediated conditionsGIL DANIEL W·Filed 2011·Granted May 19, 2015·1 cites·17 claims
- 3173US7390829B2Alpha-2 adrenergic agonistsALLERGAN INC·Filed 2005·Granted Jun 24, 2008·1 cites·8 claims
- 3272US9073888B2Coumarin compounds as receptor modulators with therapeutic utilityHEIDELBAUGH TODD M·Filed 2010·Granted Jul 7, 2015·2 cites·6 claims
- 3371US8178571B2Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the sameHEIDELBAUGH TODD M·Filed 2010·Granted May 15, 2012·1 cites·7 claims
- 3471US2020330428A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2019·Application pending·0 cites
- 3570US8828973B2Compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2014·Granted Sep 9, 2014·1 cites·12 claims
- 3670US8653062B2Compounds as receptor modulators with therapeutic utilityNGUYEN PHONG X·Filed 2010·Granted Feb 18, 2014·1 cites·16 claims
- 3769US8741875B2Compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2013·Granted Jun 3, 2014·1 cites·15 claims
- 3867US2018344692A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2018·Application pending·0 cites
- 3965US2018071260A1Methods of treating alpha adrenergic mediated conditionsALLERGAN INC·Filed 2017·Application pending·0 cites
- 4064US8071635B24-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compoundsCHOW KEN·Filed 2008·Granted Dec 6, 2011·0 cites·9 claims
- 4163US8735399B2Selective subtype alpha 2 adrenergic agents and methods for use thereofHEIDELBAUGH TODD M·Filed 2009·Granted May 27, 2014·0 cites·11 claims
- 4262US8383646B2Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compoundsALLERGAN INC·Filed 2008·Granted Feb 26, 2013·0 cites·16 claims
- 4359US8703745B1Compounds as receptor modulators with therapeutic utilityALLERGAN INC·Filed 2013·Granted Apr 22, 2014·0 cites·2 claims
- 4459US7838545B24-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonistsALLERGAN INC·Filed 2008·Granted Nov 23, 2010·0 cites·5 claims
- 4559US7795292B2Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the sameALLERGAN INC·Filed 2005·Granted Sep 14, 2010·0 cites·3 claims
- 4658US2008221152A14-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonistsALLERGAN INC·Filed 2008·Application pending·0 cites
- 4757US8119807B2Quinolynylmethylimidizoles as therapeutic agentsHEIDELBAUGH TODD M·Filed 2008·Granted Feb 21, 2012·0 cites·12 claims
- 4857US2005043305A1Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereofEURO CELTIQUE SA·Filed 2004·Application pending·0 cites
- 4957US2024034733A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5056US8183414B2N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptorsCHOW KEN·Filed 2009·Granted May 22, 2012·0 cites·8 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Phong X. Nguyen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →